● LIVE
Updated 1d ago
· 15 sources tracked
Popular antidepressant recalled over high levels of a cancer-causing compound
The FDA has recalled a popular antidepressant due to high levels of a potentially cancer-causing impurity. Breckenridge Pharmaceuticals is recalling its generic version of Cymbalta. The impurity identified in the medication is a nitrosamine.
What changed
Specific drug name and the manufacturer have been identified.
Live updates
-
FDA Recalls Nearly 375,000 Bottles of Duloxetine Over Carcinogen Risk
confidence 90%The FDA has recalled a popular antidepressant due to high levels of a potentially cancer-causing impurity. Breckenridge Pharmaceuticals is recalling its generic version of Cymbalta. The impurity identified in the medication is a nitrosamine.
What's confirmed:
- The FDA recalled nearly 375,000 bottles of the antidepressant duloxetine.
- The recall was triggered by high levels of a potentially cancer-causing impurity.
- The impurity detected in the drug is a nitrosamine.
- Breckenridge Pharmaceuticals is recalling the generic version of Cymbalta.